25.24新台幣0.14(0.55%)
2024/12/05更新
績效 / 1月1.9%
3月7.82%
1年9.98%
晨星評等 - 1.現金3.45%
- 2.股票22.51%
- 3.債券0.00%
- 4.其他74.04%
- 1.美國74.54%
- 2.歐洲不包含歐元區12.99%
- 3.英國7.23%
- 4.日本1.23%
- 5.已開發亞洲1.06%
- 1.Eli Lilly and Co9.10%
- 2.Vertex Pharmaceuticals Inc8.98%
- 3.Regeneron Pharmaceuticals Inc8.60%
- 4.Novo Nordisk AS Class B7.25%
- 5.AstraZeneca PLC7.23%
- 6.Amgen Inc6.90%
- 7.Gilead Sciences Inc5.85%
- 8.Intuitive Surgical Inc4.18%
- 9.AbbVie Inc3.92%
- 10.Lonza Group Ltd3.88%
- 1.現金3.45%
- 2.股票22.51%
- 3.債券0.00%
- 4.其他74.04%
- 1.美國74.54%
- 2.歐洲不包含歐元區12.99%
- 3.英國7.23%
- 4.日本1.23%
- 5.已開發亞洲1.06%
- 1.Eli Lilly and Co9.10%
- 2.Vertex Pharmaceuticals Inc8.98%
- 3.Regeneron Pharmaceuticals Inc8.60%
- 4.Novo Nordisk AS Class B7.25%
- 5.AstraZeneca PLC7.23%
- 6.Amgen Inc6.90%
- 7.Gilead Sciences Inc5.85%
- 8.Intuitive Surgical Inc4.18%
- 9.AbbVie Inc3.92%
- 10.Lonza Group Ltd3.88%